Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer. | BMC Gastroenterol | 2022 | 35429970 | PubTator, text mining | PubMed |
| SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. | BMC Cancer | 2022 | 35421944 | PubTator, text mining | PubMed |
| Aptamer Nanomaterials for Ovarian Cancer Target Theranostics. | Front Bioeng Biotechnol | 2022 | 35419352 | PubTator, text mining | PubMed |
| The Role of B1 Cells in Systemic Lupus Erythematosus. | Front Immunol | 2022 | 35418972 | PubTator, text mining | PubMed |
| Impaired surface marker expression in stimulated Epstein-Barr virus transformed lymphoblasts from Barth Syndrome patients. | Sci Rep | 2022 | 35418665 | PubTator, text mining | PubMed |
| Drug-induced corneal deposits: an up-to-date review. | BMJ Open Ophthalmol | 2022 | 35415268 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application. | Int J Biol Sci | 2022 | 35414783 | PubTator, text mining | PubMed |
| Reprogramming the tumor microenvironment by genome editing for precision cancer therapy. | Mol Cancer | 2022 | 35410257 | PubTator, text mining | PubMed |
| Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma. | J Clin Med | 2022 | 35407416 | PubTator, text mining | PubMed |
| Impact of Mogamulizumab in Real-Life Advanced Cutaneous T-Cell Lymphomas: A Multicentric Retrospective Cohort Study. | Cancers (Basel) | 2022 | 35406431 | PubTator, text mining | PubMed |
| 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma. | Ann Transl Med | 2022 | 35402591 | PubTator, text mining | PubMed |
| A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma. | Front Immunol | 2022 | 35401564 | PubTator, text mining | PubMed |
| Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis. | Gynecol Oncol | 2022 | 35400527 | PubTator, text mining | PubMed |
| Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands. | Front Immunol | 2022 | 35392082 | PubTator, text mining | PubMed |
| Using a Machine Learning Approach to Identify Key Biomarkers for Renal Clear Cell Carcinoma. | Int J Gen Med | 2022 | 35392028 | PubTator, text mining | PubMed |
| Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. | Signal Transduct Target Ther | 2022 | 35387984 | PubTator, text mining | PubMed |
| Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer. | Ann Med | 2022 | 35382656 | PubTator, text mining | PubMed |
| Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma. | J Clin Invest | 2022 | 35380993 | PubTator, text mining | PubMed |
| CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers. | Nat Biomed Eng | 2022 | 35379957 | PubTator, text mining | PubMed |
| Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial. | J Immunother Cancer | 2022 | 35379737 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=74